Bøger udgivet af World Health Organization

Avoiding overweight and obesity is the best-established diet-related risk factor for cancer. The proportion of people who are overweight/obese is increasing, and the amount of physical activity is decreasing in most populations, including urban populations in many developing countries. The increasing prevalence of overweight/obesity is presumably due to the increasing availability of highly palatable, high-energy foods, and an increasing sedentary lifestyle due to mechanisation of both workplace and leisure activities. Overweight/obesity and reduced physical activity increases the risk of cancers in various organs. Maintaining a healthy body weight and regular physical activity is the second most important way to prevent cancer, after tobacco control.The suggestions of possible public health actions to tackle these risk factors include the promotion of balanced diets, which are not excessive in energy, and broad education and planning to enable and encourage physical activity during work and leisure. Recommendations and a full discussion of these topics are included in the sixth volume in this series of Handbooks.

A state-of-the-art review of research findings that contribute to an understanding of hypertension and the best measures for its prevention and control, whether in individual patients or entire populations. Noting that elevated blood pressure is a massive health problem in almost every country, the report argues that programs for hypertension control should be an integral part of all national health care systems. With this goal in mind, the report aims to help policy makers appreciate the significance and complexities of hypertension, understand the options available for control and then select the most appropriate mix of interventions. Details range from recommended procedures for obtaining an accurate assessment of blood pressure through advice on the best drugs for first-line treatment of hypertensive patients to a discussion of ways to educate populations about relevant lifestyle changes Throughout the report, population-based and individual approaches are presented as complementary, synergistic strategies for hypertension control. To assist physicians as well as policy makers, the report includes abundant recommendations based on the best scientific evidence for the management of different patient groups. A section on the clinical assessment of the hypertensive patient explains the components of a coherent step-wise diagnostic process involving history taking physical examination and laboratory investigation. Included are an assessment of the most suitable drugs for first-line treatment and guidelines for developing management plans for mild hypertension, moderate and severe hypertension, resistant hypertension and hypertensive emergencies. In view of the need to assure that scarce resources are invested wisely, the report also discusses and compares the cost-effectiveness of different management strategies.

A didactic guide to all health-related measures needed to prepare for natural disasters, reduce their immediate impact, and facilitate recovery. Noting that all natural disasters share several features, the book aims to provide a framework that administrators can rely on when planning and managing the health sector's response. Details range from a list of eight misconceptions that may cause authorities to take inappropriate action, through a discussion of the sensitive issues surrounding inappropriate drug and food donations, to a distinction between responsibilities best handled by the affected country and those requiring international aid. Throughout the book, recent experiences from the Americas are used to illustrate both the impact of specific types of disaster and opportunities for mitigating their effects.

The etiology and prevention of common human cancers are the subjects of the reviews and previously unpublished research presented in this volume arising from a multidisciplinary symposium on n-nitroso compounds, tobacco and mycotoxins. Although tobacco smoking and chewing have long been established as risk factors, the possible role of nitroso compounds has inspired extensive research. The 110 papers on these three classes of carcinogenic agents cover epidemiological updates, exposures and biological monitoring, exposure prevention and dietary anti-carcinogens, and biological mechanisms and effects. The volume includes many studies of these issues from the People's Republic of China. The relevance of this work is highlighted by the fact that the cancer sites causally or putatively associated with these exposures (liver, respiratory and alimentary tracts) are those at highest risk in developed and developing nations.

The WHO Disability Assessment Schedule (WHODAS 2.0) is a unique practical instrument, based on the International Classification of Functioning, Disability and Health (ICF), that can be used to measure general health and disability levels, including mental and neurological disorders, both at the population level or in clinical practice, in a wide range of cultural settings. Presented in this book is a detailed overview of how the schedule was developed and validated, together with a description of its key features and applications. The questionnaires that form the basis of WHODAS 2.0 are available in three versions (36 item, 12 item, and 12 + 24 item), which are reproduced in the book, accompanied by detailed practical guidelines on how to use them effectively.

This book reviews the use of markers for exposure to cancer-causing or protective agents, for early signs of cancer and for individual susceptibility to cancer, in relation to chemoprevention.

The International Agency for Research on Cancer has a long experience in the compilation and analysis of data on the incidence of cancer in different parts of the world. This activity has been extended by the publication of the present volume, which brings together information on the incidence of cancer in children from over fifty countries. It represents the most extensive collection of such data ever published. The data are presented in a readily accessible format for making useful comparisons. A special classification system is employed, based upon the cellular origin of the tumors. This is more relevant than the traditional classification by anatomical site, since it is generally acknowledged that genetic susceptibility of particular cell types plays a more important role in the etiology of childhood cancers than in adults. The geographic and ethnic variations in the risk of different cancers are an invaluable resource for workers interested in formulating and confirming hypotheses concerning the causes of childhood cancer.

WHO Reporting System for Pancreaticobiliary Cytopathology is Volume 2 of this new series of reporting systems for cytopathology, which is a joint project of the International Academy of Cytology (IAC) and the International Agency for Research on Cancer (IARC), a specialized agency of the World Health Organization (WHO). The series includes a unique synthesis of the published evidence and the practice of cytopathology, and it is linked to the WHO Classification of Tumours series, now in its 5th edition. Cytopathologists look at tumours slightly differently than other specialists do, and there is a need for specialized reporting systems based on the key diagnostic cytopathological features of tumours, presented in standardized reports, within a hierarchical system of diagnostic categories. These categories must also be linked to diagnostic management recommendations to improve communication with clinicians and support patient care. And it is essential that these reporting systems be truly international, to serve the needs of patients worldwide in many differently medically resourced settings. These volumes are an essential tool for standardizing diagnostic cytopathology practice worldwide and will serve as a vehicle for the translation of cytopathology research into practice. The key diagnostic cytopathological features are listed for each tumour type under a defined set of diagnostic categories and described in precise, uniform language. These diagnostic criteria represent the first international consensus and are underpinned by evidence that has been evaluated and debated by experts in the field. Each lesion-specific section includes a dedicated subsection discussing the differential diagnosis of the cytopathological features that can be used throughout the world, including in low-resource settings, followed by a subsection describing the current best-practice application of ancillary testing (including next-generation sequencing) on cytopathology material. This volume: Prepared by about 70 authors and editors Contributors from around the world, reflecting an international expertise Hundreds of high-quality images More than 900 references

WHO Reporting System for Lung Cytopathology is Volume 1 of this new series of reporting systems for cytopathology, which is a joint project of the International Academy of Cytology (IAC) and the International Agency for Research on Cancer (IARC), a specialized agency of the World Health Organization (WHO). The series includes a unique synthesis of the published evidence and the practice of cytopathology, and it is linked to the WHO Classification of Tumours series, now in its 5th edition. Cytopathologists look at tumours slightly differently than other specialists do, and there is a need for specialized reporting systems based on the key diagnostic cytopathological features of tumours, presented in standardized reports, within a hierarchical system of diagnostic categories. These categories must also be linked to diagnostic management recommendations to improve communication with clinicians and support patient care. And it is essential that these reporting systems be truly international, to serve the needs of patients worldwide in many differently medically resourced settings. These volumes are an essential tool for standardizing diagnostic cytopathology practice worldwide and will serve as a vehicle for the translation of cytopathology research into practice. The key diagnostic cytopathological features are listed for each tumour type under a defined set of diagnostic categories and described in precise, uniform language. These diagnostic criteria represent the first international consensus and are underpinned by evidence that has been evaluated and debated by experts in the field. Each lesion-specific section includes a dedicated subsection discussing the differential diagnosis of the cytopathological features that can be used throughout the world, including in low-resource settings, followed by a subsection describing the current best-practice application of ancillary testing (including next-generation sequencing) on cytopathology material. This volume: Prepared by about 60 authors and editors Contributors from around the world, reflecting an international expertise More than 300 high-quality images More than 1000 references

Over the past two decades, there has been a major increase in research into the effects of the arts on health and well-being, alongside developments in practice and policy activities in different countries across the WHO European Region and further afield. This report synthesizes the global evidence on the role of the arts in improving health and well-being, with a specific focus on the WHO European Region. Results from over 3000 studies identified a major role for the arts in the prevention of ill health, promotion of health, and management and treatment of illness across the lifespan. The reviewed evidence included study designs such as uncontrolled pilot studies, case studies, small-scale cross-sectional surveys, nationally representative longitudinal cohort studies, community-wide ethnographies and randomized controlled trials from diverse disciplines. The beneficial impact of the arts could be furthered through acknowledging and acting on the growing evidence base; promoting arts engagement at the individual, local and national levels; and supporting cross-sectoral collaboration.

This volume summarizes the current scientific evidence and identifies research priorities needed to decrease social inequalities in cancer. The publication, based on the expert knowledge of more than 70 international scientists from multiple disciplines, undertakes a populations-within-populations approach, highlighting the large variations in cancer incidence, survival, and mortality that exist between countries and, within countries, between social groups. Several factors may lead individuals with low social status to adopt unhealthy behaviors, to be exposed to a wider range and a higher intensity of cancer risk factors, and to have reduced access to health-care services, compared with their fellow citizens. A special focus is given to how the phenomenon of inequalities in cancer evolves and is reshaped over time, driven by economic, social, political, legislative, and technological forces; it affects everyone, but the most disadvantaged individuals are particularly hard hit. This IARC Scientific Publication was developed to serve as a reference for policy-makers and public health officials, linking to specific examples of interventions that may reduce future inequalities in cancer.

This timely publication comes at a time of global interest in promoting the development of appropriate national health research systems in low and middle-income developing countries. It presents the findings of a detailed and systematic situation analysis of the national health research systems in five countries of WHO's Eastern Mediterranean Region: Egypt, Islamic Republic of Iran, Morocco, Pakistan and Sudan. The aim of the study was to pave the way for developing innovative and effective strategies for strengthening national health research systems in the Region. The experience gained will be shared with other countries in the Region and will provide a critical input to WHO's collaboration in the Region in the area of health research in the coming years.

****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Breast Tumours is the second volume in the 5th edition of the WHO series on the classification of human tumors. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumors and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. This book will be of special interest to pathologists, oncologists, surgeons and epidemiologists who manage or research breast tumors. Sections are included on all recognized neoplasms of the breast including the nipple and areola. Since the previous edition there have been changes based on recent molecular and genetic information, with impact on clinical practice.

****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Thoracic Tumours is the fifth available volume in the fifth edition of the WHO series on the classification of human tumors. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumors and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. What's new in this edition? The fifth edition, guided by the WHO Classification of Tumours Editorial Board, establishes a single coherent cancer classification presented across a collection of individual volumes organized on the basis of anatomical site (digestive system, breast, soft tissue and bone, etc.) and structured in a systematic manner, with each tumor type listed within a taxonomic classification: site, category, family (class), type, and subtype. In each volume, the entities are now listed from benign to malignant and are described under an updated set of headings, including histopathology, diagnostic molecular pathology, staging, and easy-to-read essential and desirable diagnostic criteria. Who should read this book? - Pathologists - Oncologists - Respiratory physicians - Thoracic radiologists - Cancer researchers - Surgeons - Epidemiologists> This volume: - Prepared by 217 authors and editors - Contributors from around the world - More than 1000 high-quality images - More than 3500 references

This report uses a comprehensive framework for studying health risks that was developed for the World Health Report 2002, which presented estimates for the year 2000. The report provides an update for the year 2004 for 24 global risk factors. It uses updated information from WHO programs and scientific studies for both exposure data and the causal associations of risk exposure to disease and injury outcomes. The burden of disease attributable to risk factors is measured in terms of lost years of healthy life using the metric of the disability-adjusted life year (DALY). The DALY combines years of life lost due to premature death with years of healthy life lost due to illness and disability. Health risks are in transition: populations are ageing owing to successes against infectious diseases; at the same time, patterns of physical activity and food, alcohol and tobacco consumption are changing. Low- and middle-income countries now face a double burden of increasing chronic, noncommunicable conditions, as well as the communicable diseases that traditionally affect the poor.

This item is sold only in sets of 50. This WHO booklet includes the Model International Certificate of Vaccination or Prophylaxis contained in Annex 6 of the International Health Regulations (2005). The Certificate is used for recording vaccinations or prophylaxis in accordance with the IHR (2005), including vaccination or revaccination against yellow fever. Additional pages in the booklet have space for recording other vaccinations. (Please note the World Health Organization intends for these ICV sets to be sold to professional health organizations and companies that provide vaccination services. If you are an individual in need of one ICV booklet, please contact your local health provider, who should be able to give you one free of charge.)